Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 1/2 12Phase 1 9Phase 3 7Phase NA 6Phase 2/3 2Phase EARLY_PHASE1 1Phase 4 1

Status

Unknown 3Completed 3Withdrawn 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 2Lymphoid 1Gynecologic 1

Conditions

Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Lymphoma, B-Cell, Marginal Zone 1Locally Advanced Bladder Cancer 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Pharmaceutical Preparations × Clear all
NCT05263219 2023-06-22

DEB-TACE+HAIC vs. HAIC for Large HCC

Second Affiliated Hospital of Guangzhou Medical University

Phase 3 Unknown
230 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02973685 2023-06-12

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Sun Yat-sen University

Phase 3 Completed
315 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00210353 2019-06-06

Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma

International Extranodal Lymphoma Study Group (IELSG)

Phase 3 Completed
454 enrolled 16 charts
Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT03791918 2019-05-02

Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria

Sun Yat-sen University

Phase 3 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT02036164 2017-04-06

ACT-LACC

Navamindradhiraj University

Phase 3 Unknown
500 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT01734798 2012-11-28

Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer

Cairo University

Phase 3 Completed
198 enrolled
Genitourinary

Locally Advanced Bladder Cancer

NCT00201630 2005-09-20

Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy

New York Prostate Institute

Phase 3 Unknown
150 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡